What's wrong with Steve Jobs? Apple won't say. On Monday, the company said he was taking a
medical leave—his third since 2004—but
refused to disclose why. Yesterday
Apple touted its market prospects in a conference call but again
said nothing about its CEO's health. You can argue that Jobs' medical privacy is more important than the
interests of Apple's investors. But there's another reason why he should tell us what's going on, and it's bigger than money. It's life and death.
Two years ago, Jobs
gamed the transplant allocation system to get a liver that could have saved somebody else. At the time, skeptics doubted that he should have received the organ, since he'd been
treated for pancreatic cancer—in fact, he may have sought the liver because of the cancer—and the likelihood of the cancer's recurrence made him a bad bet for putting the liver to best use. If his health is now failing because of the cancer, that suspicion may be vindicated.
Jobs lives in Northern California, but
he got his liver in Tennessee. Why? Different parts of the country have different waiting lists, and the wait in Northern California was
three times longer than the wait in Tennessee. In fact, the median wait in the Tennessee area where Jobs snagged his liver was around
15 percent of the national average. Jobs confirmed last year that
this is why he went to Tennessee: "My doctors here advised me to enroll in a transplant program in Memphis, Tennessee, where the supply/demand ratio of livers is more favorable than it is in California here." Legally, you're allowed to get on multiple waiting lists around the country. That's how you game the system.
So why doesn't everybody do this?
Because they can't. First you have to show up for an extensive in-person evaluation. Then you have to be available for a transplant in the area within hours of an organ becoming available. And while one jurisdiction might accept you as a charity case, if you want to play the field you'll have to prove you can pay for the transplant yourself. You also get priority points for being able to guarantee follow-up medical care, since this assures transplant allocators that the organ will be well cared for.
Ordinary people can't compete with billionaires at meeting these tests. They can't go to multiple states for evaluations. They don't have private jets. Their insurance doesn't cover multiple evaluations and may not cover much of the
half-million dollar transplant, much less the follow-up care.
<snip>
http://www.slate.com/id/2281668/:popcorn: